Chinese, U.S. Researchers Isolate Ovarian Cancer Bio-Markers
This article was originally published in PharmAsia News
Executive Summary
Researchers from mainland China and Taiwan working with U.S. colleagues say they were able to identify bio-markers in ovarian tumors that might lead to improvements in current cancer treatment. Previous work had identified cancer stem cells in several tumor types, including brain and breast cancer, but the multinational research team has now located them in ovarian tumor tissues. Two bio-markers, CD44 and CD117, were identified as specific only to ovarian cancer cells. (Click here for more